Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective

Elena Klenova; Gillie Evans; Neil Meardon; Jan Clark; Yvonne Diaz

doi:10.1136/bmjonc-2025-000974

January 1, 2026BMJ OncologyOpen Access

Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective

View Full Paper

Ask AI

Bookmark

Share

Key Points

To discuss the perspectives of patients and advocates on the use of surgery for oncogene-driven stage IV NSCLC.
Gather insights from patient advocates and community founders.
Explore the role of surgery as a consolidation therapy before disease progression.
Highlight the importance of patient and advocacy perspectives in treatment decisions.
Demonstrate a need for incorporating patient feedback into surgical approaches for NSCLC.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Editorial addresses surgery's role in managing oncogene-driven stage IV NSCLC, emphasizing patient perspectives.

Abstract

The authors of this editorial are patients, advocates and founders of communities representing people living with oncogene-driven non-small cell lung cancer (NSCLC).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Klenova et al. (2026) studied this question.

synapsesocial.com/papers/69c4cd80fdc3bde448919efa https://doi.org/10.1136/bmjonc-2025-000974

View Full Paper

Ask AI

Bookmark

Share

Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading